Discovery of Potential Antileishmanial Compounds Through Phenotypic Screening of an Alkaloid Library
Molecules · 28.10.2025 · 30 (21) · 4210
DOI: 10.3390/molecules30214210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 28.10.2025. Verfasst von Cathy Soh-Kamdjo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ciencias Biomédicas, Facultad de Veterinaria, Universidad de León, Campus de Vegazana s/n, 24007 León, Spain. Hauptthemen laut MEDLINE: Antiprotozoal Agents, Leishmania donovani, Alkaloids, Drug Discovery. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Visceral leishmaniasis caused by Leishmania donovani is one of the major neglected tropical diseases attributable to parasitic protozoa. In the absence of an effective vaccine, chemotherapy remains the only available therapeutic option. However, current treatments rely on a limited number of drugs that are largely obsolete, highly toxic or require intravenous administration, and their extensive use has led to the emergence of drug resistance. Consequently, the discovery of new antileishmanial agents is an urgent priority. In this study, a commercial library of 449 alkaloids in a high-throughput screening format was evaluated against both axenic bone marrow-derived amastigotes and intramacrophagic amastigotes from mice infected with L. donovani IRFP, a strain engineered to emit infrared fluorescence in its viable form. Six isoquinoline-type alkaloids showed the best antileishmanial efficacy against intramacrophagic amastigotes while exhibiting minimal cytotoxicity toward RAW 264.7 and HepG2 cell lines, with a promising selective index higher than four, and good mouse intestinal tolerance in mouse organoids. Among these compounds, the protoberberine scaffold emerged as the most promising candidate for further drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Ciencias Biomédicas, Facultad de Veterinaria, Universidad de León, Campus de Vegazana s/n, 24007 León, Spain.
- Instituto de Biomedicina (IBIOMED), Universidad de León, Campus de Vegazana s/n, 24007 León, Spain.
ORCID-Profile: Cathy Soh-Kamdjo, María-Cristina González-Montero, Carlos García-Estrada, Estela Melcón-Fernández, Celia Fernández-Rubio, Yolanda Pérez-Pertejo, Rosa M Reguera, Rafael Balaña-Fouce
Zitieren
APA
Soh-Kamdjo, C., González-Montero, M. C., García-Estrada, C., Melcón-Fernández, E., Fernández-Rubio, C., Pérez-Pertejo, Y., Reguera, R. M., & Balaña-Fouce, R. (2025). Discovery of Potential Antileishmanial Compounds Through Phenotypic Screening of an Alkaloid Library. Molecules, 30(21), 4210. https://doi.org/10.3390/molecules30214210
Vancouver
Soh-Kamdjo C, González-Montero MC, García-Estrada C, Melcón-Fernández E, Fernández-Rubio C, Pérez-Pertejo Y, et al. Discovery of Potential Antileishmanial Compounds Through Phenotypic Screening of an Alkaloid Library. Molecules. 2025;30(21):4210. doi:10.3390/molecules30214210
BibTeX
@article{SohKamdjo2025,
author = {Soh-Kamdjo, Cathy and González-Montero, María-Cristina and García-Estrada, Carlos and Melcón-Fernández, Estela and Fernández-Rubio, Celia and Pérez-Pertejo, Yolanda and Reguera, Rosa M and Balaña-Fouce, Rafael},
title = {Discovery of Potential Antileishmanial Compounds Through Phenotypic Screening of an Alkaloid Library},
journal = {Molecules},
year = {2025},
volume = {30},
number = {21},
pages = {4210},
doi = {10.3390/molecules30214210}
}
EUVIMED